- Types of Brain Cancer

Popular
Fibrosarcoma Causes of Anal Cancer Symptoms of Anal Cancer Osteosarcoma Osteogenic Sarcoma Ewing’s sarcoma Diagnosis of Anal Cancer Causes of Bladder Cancer Treatment of Anal Cancer Bladder Cancer Treatment Types Of Bone Cancer

Slick RSS

MedicineNet Cancer General

MedicineNet Cancer General

Gene Test Could Predict Colon Cancer's Return
Title: Gene Test Could Predict Colon Cancer's Return
Category: Health News
Created: 11/26/2008 2:00:00 AM
Last Editorial Review: 11/26/2008
Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
Title: Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
Category: Health News
Created: 11/26/2008 2:00:00 AM
Last Editorial Review: 11/26/2008
U.S. Cancer Deaths, New Cancers Decline
Title: U.S. Cancer Deaths, New Cancers Decline
Category: Health News
Created: 11/26/2008
Last Editorial Review: 11/26/2008
Weight Boosts Older Women's Breast Cancer Risk
Title: Weight Boosts Older Women's Breast Cancer Risk
Category: Health News
Created: 11/26/2008 2:00:00 AM
Last Editorial Review: 11/26/2008
Can Breast Cancer Disappear?
Title: Can Breast Cancer Disappear?
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008

MedicineNet Depression General

MedicineNet Depression General

paroxetine, Paxil, Paxil CR, Paxeva
Title: paroxetine, Paxil, Paxil CR, Paxeva
Category: Medications
Created: 12/31/1997
Last Editorial Review: 11/26/2008
Depression May Up Heart Attack Risk
Title: Depression May Up Heart Attack Risk
Category: Health News
Created: 11/26/2008
Last Editorial Review: 11/26/2008
'Off-Label' Drug Use Is Common
Title: 'Off-Label' Drug Use Is Common
Category: Health News
Created: 11/25/2008
Last Editorial Review: 11/25/2008
Holidays: Avoid Holiday Burnout: Four Keys to Sane and Healthy Holidays
Title: Holidays: Avoid Holiday Burnout: Four Keys to Sane and Healthy Holidays
Category: Doctor's Views
Created: 12/8/2005
Last Editorial Review: 11/24/2008
Banzel Approved for Lennox-Gastaut Syndrome
Title: Banzel Approved for Lennox-Gastaut Syndrome
Category: Health News
Created: 11/22/2008 2:00:00 AM
Last Editorial Review: 11/24/2008

Cancer / Oncology News From Medical News Today

Latest Cancer / Oncology News From Medical News Today.

Prostate Cancer Promotes The Growth Of New Nerves And The Branching Axons That Carry Their Messages
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches.
Study Unmasks How Ovarian Tumors Evade Immune System
Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body's immune system, leaving the disease to spread unchecked. Ovarian cancer is considered to be one of the most aggressive malignancies, killing more than 70 percent of diagnosed women within five years, including an estimated 15,000 this year.
Merck Serono: European Commission Approves Erbitux For 1st-Line Use In Head And Neck Cancer
Merck Serono, a division of Merck KGaA, announced today that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux® (cetuximab) to include 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination with radiotherapy for locally advanced disease.
Dynamic Change In Phosphorylated PDGFR In Peripheral Blood Leukocytes After Docetaxel Therapy Predicts Overall Survival In Prostate Cancer
UroToday.com - Accurate molecular markers for targeted therapy that correlate with traditional clinical outcomes are not common. An online article from a distinguished group of researchers demonstrates how useful this approach may be. As background, the combination of platelet-derived growth factor receptor (PDGFR) inhibition and taxane chemotherapy for CaP patients with bone metastasis has not demonstrated improved progression-free survival or overall survival benefit.